These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 31030323)

  • 1. Contradictory to its effects on thrombin, C1-inhibitor reduces plasmin generation in the presence of thrombomodulin.
    Tarandovskiy ID; Rajabi AA; Karnaukhova E; Buehler PW
    J Thromb Thrombolysis; 2019 Jul; 48(1):81-87. PubMed ID: 31030323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C1-esterase inhibitor enhances thrombin generation and spatial fibrin clot propagation in the presence of thrombomodulin.
    Tarandovskiy ID; Buehler PW; Ataullakhanov FI; Karnaukhova E
    Thromb Res; 2019 Apr; 176():54-60. PubMed ID: 30784776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex-dependent balance between thrombin and plasmin generation in the presence of thrombomodulin.
    Tarandovskiy ID; Buehler PW; Karnaukhova E
    J Thromb Thrombolysis; 2023 Apr; 55(3):566-570. PubMed ID: 36508084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous measurement of thrombin and plasmin generation to assess the interplay between coagulation and fibrinolysis.
    Matsumoto T; Nogami K; Shima M
    Thromb Haemost; 2013 Oct; 110(4):761-8. PubMed ID: 24072166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interspecies comparison of simultaneous thrombin and plasmin generation.
    Tarandovskiy ID; Shin HKH; Baek JH; Karnaukhova E; Buehler PW
    Sci Rep; 2020 Mar; 10(1):3885. PubMed ID: 32127577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of coagulation and fibrinolysis in patients with angioedema due to C1-inhibitor deficiency.
    van Geffen M; Cugno M; Lap P; Loof A; Cicardi M; van Heerde W
    Clin Exp Immunol; 2012 Mar; 167(3):472-8. PubMed ID: 22288590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A high-fat diet delays plasmin generation in a thrombomodulin-dependent manner in mice.
    Miszta A; Kopec AK; Pant A; Holle LA; Byrnes JR; Lawrence DA; Hansen KC; Flick MJ; Luyendyk JP; de Laat B; Wolberg AS
    Blood; 2020 May; 135(19):1704-1717. PubMed ID: 32315384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombomodulin in human plasma contributes to inhibit fibrinolysis through acceleration of thrombin-dependent activation of plasma procarboxypeptidase B.
    Hosaka Y; Takahashi Y; Ishii H
    Thromb Haemost; 1998 Feb; 79(2):371-7. PubMed ID: 9493593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein C inhibitor acts as a procoagulant by inhibiting the thrombomodulin-induced activation of protein C in human plasma.
    Elisen MG; von dem Borne PA; Bouma BN; Meijers JC
    Blood; 1998 Mar; 91(5):1542-7. PubMed ID: 9473218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of factor XIa on thrombin and plasmin generation, clot formation, lysis and density in coagulation factors deficiencies.
    Tarandovskiy ID; Ovanesov MV
    Thromb Res; 2024 Jan; 233():189-199. PubMed ID: 38101192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High plasma levels of C1-inhibitor are associated with lower risk of future venous thromboembolism.
    Grover SP; Snir O; Hindberg K; Englebert TM; Braekkan SK; Morelli VM; Jensen SB; Wolberg AS; Mollnes TE; Ueland T; Mackman N; Hansen JB
    J Thromb Haemost; 2023 Jul; 21(7):1849-1860. PubMed ID: 37003465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rivaroxaban pharmacodynamics in healthy volunteers evaluated with thrombin generation and the active protein C system: Modeling and assessing interindividual variability.
    Siguret V; Abdoul J; Delavenne X; Curis E; Carlo A; Blanchard A; Salem JE; Gaussem P; Funck-Brentano C; Azizi M; Mismetti P; Loriot MA; Lecompte T; Gouin-Thibault I
    J Thromb Haemost; 2019 Oct; 17(10):1670-1682. PubMed ID: 31215111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C1 inhibitor deficiency enhances contact pathway-mediated activation of coagulation and venous thrombosis.
    Grover SP; Kawano T; Wan J; Tanratana P; Polai Z; Shim YJ; Snir O; Brækkan S; Dhrolia S; Kasthuri RR; Bendapudi PK; McCrae KR; Wolberg AS; Hansen JB; Farkas H; Mackman N
    Blood; 2023 May; 141(19):2390-2401. PubMed ID: 36701760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombomodulin: a linker of coagulation and fibrinolysis and predictor of risk of arterial thrombosis.
    Wu KK; Matijevic-Aleksic N
    Ann Med; 2000 Dec; 32 Suppl 1():73-7. PubMed ID: 11209986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A direct oral anticoagulant edoxaban accelerated fibrinolysis via enhancement of plasmin generation in human plasma: dependent on thrombin-activatable fibrinolysis inhibitor.
    Morishima Y; Honda Y
    J Thromb Thrombolysis; 2019 Jul; 48(1):103-110. PubMed ID: 30972711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein C inhibitor regulates the thrombin-thrombomodulin complex in the up- and down regulation of TAFI activation.
    Mosnier LO; Elisen MG; Bouma BN; Meijers JC
    Thromb Haemost; 2001 Oct; 86(4):1057-64. PubMed ID: 11686324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Regulatory mechanism of fibrinolysis system by thrombin activatable fibrinolysis inhibitor (TAFI)].
    Urano T
    Nihon Yakurigaku Zasshi; 2000 Nov; 116(5):298-303. PubMed ID: 11215380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of thrombophilia-related plasmas evaluated by anticoagulants-mediated thrombin and plasmin generation assays.
    Hashimoto N; Ogiwara K; Matsumoto T; Furukawa S; Takeyama M; Nogami K
    Blood Coagul Fibrinolysis; 2022 Sep; 33(6):327-336. PubMed ID: 35981254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombin-independent thrombin inhibitors, but not direct factor Xa inhibitors, enhance thrombin generation in plasma through inhibition of thrombin-thrombomodulin-protein C system.
    Furugohri T; Sugiyama N; Morishima Y; Shibano T
    Thromb Haemost; 2011 Dec; 106(6):1076-83. PubMed ID: 22012070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombomodulin enhances the invasive activity of mouse mammary tumor cells.
    Niimi S; Harashima M; Takayama K; Hara M; Hyuga M; Seki T; Ariga T; Kawanishi T; Hayakawa T
    J Biochem; 2005 May; 137(5):579-86. PubMed ID: 15944410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.